Totally implantable venous access devices: retrospective analysis of different insertion techniques and predictors of complications in 796 devices implanted in a single institution

BMC Surgery

Research Article

Angelo Ciccarese¹  Sandra Cappellato¹  Muzio Meroni¹  Connie Celentano¹  Elisa Granziera¹  Valentina Manfredi¹  Bogdan Filip²  Matteo Cagol³  Marco Scarpa³  Carlo Castoro³  Rita Alfieri³ 

[1] Anestesiology Unit, Veneto Institute of Oncology (IOV-IRCCS), Padova, Italy;Department of Surgery, Iasi University Hospital, Iasi, Romania;Surgical Oncology Unit, Veneto Institute of Oncology (IOV-IRCCS), Padova, Italy;

关键词: Totally implantable venous access device;    US guided;    Chemotherapy;   

DOI  :  10.1186/1471-2482-14-27

 received in 2013-09-10, accepted in 2014-04-25,  发布年份 2014

来源: Springer

【 摘 要 】

BackgroundThe aim of this study was to assess the efficacy and safety of totally implanted vascular devices (TIVAD) using different techniques of insertion.MethodsWe performed a retrospective study using a prospective collected database of 796 consecutive oncological patients in which TIVADs were inserted. We focused on early and late complications following different insertion techniques (surgical cutdown, blind and ultrasound guided percutaneous) according to different techniques.ResultsUltrasound guided technique was used in 646 cases, cephalic vein cutdown in 102 patients and percutaneous blind technique in 48 patients. The overall complication rate on insertion was 7.2% (57 of 796 cases). Early complications were less frequent using the ultrasound guided technique: arterial puncture (p = 0.009), technical failure (p = 0.009), access site change after first attempt (p = 0.002); pneumothorax occurred in 4 cases, all using the blind percutaneus technique. Late complications occurred in 49 cases (6.1%) which required TIVAD removal in 43 cases and included: sepsis (29 cases), thrombosis (3 cases), dislocation (7 cases), skin dehiscence (3 cases), and severe pain (1 case).ConclusionUltrasound guided technique is the safest option for TIVAD insertion, with the lowest rates of immediate complications.

【 授权许可】

Unknown   
© Granziera et al.; licensee BioMed Central Ltd. 2014. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.